Aurobind Vidyarthi

958 total citations
19 papers, 725 citations indexed

About

Aurobind Vidyarthi is a scholar working on Immunology, Infectious Diseases and Oncology. According to data from OpenAlex, Aurobind Vidyarthi has authored 19 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 7 papers in Infectious Diseases and 5 papers in Oncology. Recurrent topics in Aurobind Vidyarthi's work include Immune Cell Function and Interaction (7 papers), Tuberculosis Research and Epidemiology (6 papers) and Immune cells in cancer (4 papers). Aurobind Vidyarthi is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Tuberculosis Research and Epidemiology (6 papers) and Immune cells in cancer (4 papers). Aurobind Vidyarthi collaborates with scholars based in India, United States and France. Aurobind Vidyarthi's co-authors include Nargis Khan, Javed N. Agrewala, Javed N. Agrewala, Shikha Negi, Oscar R. Colegio, Tapan Agnihotri, Mohammad Aqdas, Manoj Kumar Tewari, Deepyan Chatterjee and Diana A. Yanez and has published in prestigious journals such as The Journal of Experimental Medicine, Immunity and PLoS ONE.

In The Last Decade

Aurobind Vidyarthi

18 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurobind Vidyarthi India 13 395 264 208 157 109 19 725
Lucia E. Rosas United States 18 481 1.2× 93 0.4× 194 0.9× 292 1.9× 150 1.4× 29 1.1k
Wen-Hsuan W. Lin United States 16 441 1.1× 218 0.8× 165 0.8× 309 2.0× 158 1.4× 33 857
Tamara C. Pozos United States 8 352 0.9× 272 1.0× 222 1.1× 238 1.5× 82 0.8× 17 812
Nicole Meissner United States 17 294 0.7× 148 0.6× 127 0.6× 250 1.6× 55 0.5× 28 709
J. Michael Stolley United States 12 656 1.7× 176 0.7× 197 0.9× 107 0.7× 226 2.1× 17 939
Marı́a del Carmen Sasiain Argentina 18 427 1.1× 443 1.7× 130 0.6× 315 2.0× 76 0.7× 38 793
Fuping Zhang China 15 849 2.1× 174 0.7× 290 1.4× 185 1.2× 173 1.6× 32 1.3k
Patrícia Neves Brazil 14 713 1.8× 212 0.8× 149 0.7× 152 1.0× 89 0.8× 28 1.1k
Fariba Tahami United Kingdom 7 474 1.2× 344 1.3× 109 0.5× 316 2.0× 43 0.4× 12 761

Countries citing papers authored by Aurobind Vidyarthi

Since Specialization
Citations

This map shows the geographic impact of Aurobind Vidyarthi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurobind Vidyarthi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurobind Vidyarthi more than expected).

Fields of papers citing papers by Aurobind Vidyarthi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurobind Vidyarthi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurobind Vidyarthi. The network helps show where Aurobind Vidyarthi may publish in the future.

Co-authorship network of co-authors of Aurobind Vidyarthi

This figure shows the co-authorship network connecting the top 25 collaborators of Aurobind Vidyarthi. A scholar is included among the top collaborators of Aurobind Vidyarthi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurobind Vidyarthi. Aurobind Vidyarthi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Vidyarthi, Aurobind & Joe Craft. (2024). CBLs downregulation foretells T cell ubiquitination leading to autoimmunity. Cell chemical biology. 31(7). 1239–1241.
2.
Meli, Alexandre P., Antariksh Tyagi, Aurobind Vidyarthi, et al.. (2024). The amalgam of naive CD4+ T cell transcriptional states is reconfigured by helminth infection to dampen the amplitude of the immune response. Immunity. 57(8). 1893–1907.e6. 5 indexed citations
3.
Seth, Abhinav, et al.. (2023). AP-1–independent NFAT signaling maintains follicular T cell function in infection and autoimmunity. The Journal of Experimental Medicine. 220(5). 6 indexed citations
4.
Jiang, Xiaodong, et al.. (2023). Functionally and Metabolically Divergent Melanoma-Associated Macrophages Originate from Common Bone-Marrow Precursors. Cancers. 15(13). 3330–3330. 5 indexed citations
5.
Mittal, Amit, Mike Wang, Aurobind Vidyarthi, et al.. (2021). Topical arginase inhibition decreases growth of cutaneous squamous cell carcinoma. Scientific Reports. 11(1). 10731–10731. 12 indexed citations
6.
Kurokawa, Cheyne, Sukanya Narasimhan, Aurobind Vidyarthi, et al.. (2020). Repeat tick exposure elicits distinct immune responses in guinea pigs and mice. Ticks and Tick-borne Diseases. 11(6). 101529–101529. 25 indexed citations
7.
Vidyarthi, Aurobind, Tapan Agnihotri, Nargis Khan, et al.. (2019). Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity. Cancer Immunology Immunotherapy. 68(12). 1995–2004. 108 indexed citations
8.
Vidyarthi, Aurobind, Nargis Khan, Tapan Agnihotri, et al.. (2018). TLR-3 Stimulation Skews M2 Macrophages to M1 Through IFN-αβ Signaling and Restricts Tumor Progression. Frontiers in Immunology. 9. 1650–1650. 126 indexed citations
9.
Vidyarthi, Aurobind, Nargis Khan, Tapan Agnihotri, et al.. (2017). Antibody response against PhoP efficiently discriminates among healthy individuals, tuberculosis patients and their contacts. PLoS ONE. 12(3). e0173769–e0173769. 5 indexed citations
10.
Yanez, Diana A., et al.. (2017). The role of macrophages in skin homeostasis. Pflügers Archiv - European Journal of Physiology. 469(3-4). 455–463. 81 indexed citations
11.
Khan, Nargis, Aurobind Vidyarthi, Susanta Pahari, et al.. (2016). Signaling through NOD-2 and TLR-4 Bolsters the T cell Priming Capability of Dendritic cells by Inducing Autophagy. Scientific Reports. 6(1). 19084–19084. 39 indexed citations
12.
Khan, Nargis, et al.. (2016). Innate Immunity Holding the Flanks until Reinforced by Adaptive Immunity against Mycobacterium tuberculosis Infection. Frontiers in Microbiology. 7. 328–328. 31 indexed citations
13.
Khan, Nargis, Susanta Pahari, Aurobind Vidyarthi, Mohammad Aqdas, & Javed N. Agrewala. (2016). Stimulation through CD40 and TLR-4 Is an Effective Host Directed Therapy against Mycobacterium tuberculosis. Frontiers in Immunology. 7. 386–386. 24 indexed citations
14.
Khan, Nargis, Mohammad Aqdas, Aurobind Vidyarthi, et al.. (2016). Triggering through NOD-2 Differentiates Bone Marrow Precursors to Dendritic Cells with Potent Bactericidal activity. Scientific Reports. 6(1). 27263–27263. 7 indexed citations
15.
Khan, Nargis, et al.. (2016). Alteration in the Gut Microbiota Provokes Susceptibility to Tuberculosis. Frontiers in Immunology. 7. 529–529. 104 indexed citations
16.
Khan, Nargis, Aurobind Vidyarthi, Mohammed Amir, Khurram Mushtaq, & Javed N. Agrewala. (2016). T-cell exhaustion in tuberculosis: pitfalls and prospects. Critical Reviews in Microbiology. 43(2). 133–141. 71 indexed citations
17.
Khan, Nargis, Aurobind Vidyarthi, Susanta Pahari, & Javed N. Agrewala. (2015). Distinct Strategies Employed by Dendritic Cells and Macrophages in RestrictingMycobacterium tuberculosisInfection: Different Philosophies but Same Desire. International Reviews of Immunology. 35(5). 386–398. 18 indexed citations
18.
Khan, Nargis, Susanta Pahari, Aurobind Vidyarthi, Mohammad Aqdas, & Javed N. Agrewala. (2015). NOD-2 and TLR-4 Signaling Reinforces the Efficacy of Dendritic Cells and Reduces the Dose of TB Drugs against <b><i>Mycobacterium tuberculosis</i></b>. Journal of Innate Immunity. 8(3). 228–242. 28 indexed citations
19.
Chodisetti, Sathi Babu, Uthaman Gowthaman, Pradeep Kumar, et al.. (2014). Triggering Through Toll-like Receptor 2 Limits Chronically Stimulated T-helper Type 1 Cells From Undergoing Exhaustion. The Journal of Infectious Diseases. 211(3). 486–496. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucia E. Rosas Breakdown of academic impact, for papers by Wen-Hsuan W. Lin Breakdown of academic impact, for papers by Tamara C. Pozos Breakdown of academic impact, for papers by Nicole Meissner Breakdown of academic impact, for papers by J. Michael Stolley Breakdown of academic impact, for papers by Marı́a del Carmen Sasiain Breakdown of academic impact, for papers by Fuping Zhang Breakdown of academic impact, for papers by Patrícia Neves Breakdown of academic impact, for papers by Fariba Tahami
Rankless by CCL
2026